Patent · US Active

Compositions and methods for treating or limiting development of age-related macular degeneration

US11969401B2 · kind B2 · utility

0Cited by

9References

17Claims

0Family size

Assignee

Arizona Board of Regents on Behalf of the University of Arizona · US

Inventors

Robert E. Snyder · Uniontown, US
Brian McKay · Marana, US

Key dates

Filing date	Jan 30, 2020
Grant date	Apr 30, 2024
Priority date	—
Expiry date	Sep 17, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides methods for treating or limiting development age-related macular degeneration, comprising (a) a GPR143 receptor agonist, including but not limited to L-DOPA, L-DOPA analogues, or a pharmaceutically acceptable salt thereof, and (b) melatonin, a melatonin analogue, or a pharmaceutically acceptable salt thereof, and related compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.